Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical development and approval of COVID-19 vaccines.
Kalinke U, Barouch DH, Rizzi R, Lagkadinou E, Türeci Ö, Pather S, Neels P. Kalinke U, et al. Among authors: rizzi r. Expert Rev Vaccines. 2022 May;21(5):609-619. doi: 10.1080/14760584.2022.2042257. Epub 2022 Mar 14. Expert Rev Vaccines. 2022. PMID: 35157542 Free PMC article.
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine.
Pather S, Charpentier N, van den Ouweland F, Rizzi R, Finlayson A, Salisch N, Muik A, Lindemann C, Khanim R, Abduljawad S, Smith ER, Gurwith M, Chen RT; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group (BRAVATO; ex-V3SWG). Pather S, et al. Among authors: rizzi r. Vaccine. 2024 Sep 17;42(22):126165. doi: 10.1016/j.vaccine.2024.126165. Epub 2024 Aug 27. Vaccine. 2024. PMID: 39197299 Free article. Review.
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study.
Patel P, Macdonald JC, Boobalan J, Marsden M, Rizzi R, Zenon M, Ren J, Chu H, Cappelleri JC, Roychoudhury S, O'Brien J, Izaki-Lee K, Boyce D. Patel P, et al. Among authors: rizzi r. Front Med (Lausanne). 2023 Nov 8;10:1275817. doi: 10.3389/fmed.2023.1275817. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38020129 Free PMC article.
Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia-Romagna region, Italy.
Di Vito L, Matteo E, Meletti S, Zenesini C, Bernabè G, Bomprezzi C, Casadio MC, Castioni CA, Cesnik E, Coniglio C, Currò-Dossi M, De Massis P, Fallica E, Florindo I, Giovannini G, Guarino M, Marchesi E, Marudi A, Merli E, Monti G, Orlandi N, Pasini E, Passarelli D, Rinaldi R, Rizzi R, Romoli M, Santangelo M, Tontini V, Turchi G, Volpini M, Zini A, Zinno L, Michelucci R, Vignatelli L, Tinuper P, Bisulli F; STEPPER study group. Di Vito L, et al. Among authors: rizzi r. Epilepsia. 2024 Dec 21. doi: 10.1111/epi.18227. Online ahead of print. Epilepsia. 2024. PMID: 39707958
To be or not to be: The dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma - a systematic review and meta-analysis.
Rossi J, Cavallieri F, Bassi MC, Venturelli F, Toschi G, Di Rauso G, Lucchi C, Donati B, Rizzi R, Russo M, Bondavalli M, Iaccarino C, Pavesi G, Neri A, Biagini G, Ciarrocchi A, Rossi PG, Pisanello A, Valzania F. Rossi J, et al. Among authors: rizzi r. BMC Cancer. 2024 Dec 3;24(1):1488. doi: 10.1186/s12885-024-13249-8. BMC Cancer. 2024. PMID: 39627753 Free PMC article.
447 results